Ruihong Li

Title: Innovations of Ruihong Li in Sustained Delivery Formulations

Introduction

Ruihong Li is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sustained delivery systems for therapeutic compounds.

Latest Patents

Ruihong Li holds a patent for "Sustained delivery formulations of rapamycin compounds." This invention relates to a rapamycin sustained release delivery system designed for the treatment of diseases that respond to rapamycin. The system includes a flowable composition containing rapamycin or a rapamycin derivative, which can be injected into tissue. Upon injection, the composition coagulates to form a solid or gel implant. The formulation consists of a biodegradable, thermoplastic polymer, an organic liquid, and rapamycin or its derivatives.

Career Highlights

Ruihong Li is currently associated with Tolmar Therapeutics, Inc., where he continues to innovate in the field of drug delivery systems. His work focuses on enhancing the efficacy and safety of therapeutic agents through advanced formulation techniques.

Collaborations

Ruihong Li collaborates with notable professionals in his field, including Philippe Maria Clotaire Margaron and Eric Dadey. These collaborations contribute to the advancement of research and development in pharmaceutical technologies.

Conclusion

Ruihong Li's innovative work in sustained delivery formulations exemplifies the potential of advanced drug delivery systems in modern medicine. His contributions are paving the way for more effective treatments for various diseases.